Lipid-related Products for Obesity Research
InquiryObesity drives metabolic syndrome, type 2 diabetes, cardiovascular disease, and non alcoholic fatty liver conditions, all characterized molecularly by dysregulated lipid homeostasis. Excessive triacylglycerol storage in white adipose tissue and ectopic lipid accumulation in muscle, liver, and pancreatic beta cells trigger lipotoxicity, inflammation, and insulin resistance. Balancing lipogenesis, lipolysis, fatty acid oxidation, and lipid signaling is therefore essential for antiobesity target discovery and lead optimization.
Beyond energy storage, bioactive lipids act as key secondary messengers controlling nuclear receptor transcription, cellular stress, and energy expenditure. Species such as ceramides, diacylglycerols, sphingolipids, PPAR ligands, and short-chain fatty acids regulate adipocyte differentiation, thermogenesis, and satiety. Precise quantitative profiling and targeted modulation of these lipid species are vital for metabolic drug discovery.
Lipid-Related Products for Obesity Research: Accelerating Antiobesity Therapeutics and Metabolic Discovery
Protheragen provides high-purity lipid standards, bioactive tools, custom synthesis, and screening platforms. Backed by over two decades of lipid biochemistry expertise, we empower researchers to dissect lipid pathways, validate targets, and advance therapeutics across adipogenesis inhibition, thermogenesis activation, lipotoxicity mitigation, and lipid nanoparticle (LNP) nucleic acid delivery.
A comprehensive portfolio of ultra-high-purity lipid standards, endogenous metabolites, and biochemical tools designed for exceptional batch-to-batch consistency in modeling, measuring, and mimicking lipid signaling, adipose biology, and energy homeostasis.
- Triacylglycerols, diacylglycerols, and free fatty acids for lipid droplet and lipolysis assays
- Ceramides, sphingomyelins, and acylcarnitines for lipotoxicity and insulin resistance research
- Short-chain fatty acids including acetate, propionate, and butyrate for gut-lung metabolic crosstalk studies
- Sterols, phospholipids, and oxysterols for cellular membrane and metabolic receptor signaling studies
Next-generation structural, ionizable, and helper lipids engineered to build high-performance delivery vehicles for nucleic acids and small molecules.
- Ionizable cationic lipids with tuned pKa values for efficient nucleic acid endosomal escape
- Helper lipids including DOPE, DSPC, and Cholesterol derivatives for structural stabilization
- PEGylated lipids for optimized circulation kinetics and reduced non-specific uptake
- Adipose and liver targeted formulations engineered for organ-specific therapeutic delivery
Potent bioactive molecules designed to activate, inhibit, or fine-tune key enzymes and receptors controlling lipid metabolism.
- PPAR agonists and antagonists modulating adipogenesis, thermogenesis, and fatty acid oxidation
- Endocannabinoid and free fatty acid receptor ligands regulating appetite, gut motility, and lipid storage
- Lipase and acyltransferase inhibitors targeting triglyceride synthesis and lipolytic pathways
- Metabolic enzyme modulators focusing on AMPK, ACC, and DGAT pathway regulation
High-sensitivity molecular probes and stable isotope-labeled standards designed for clear visualization and precise quantification.
- Fluorescent lipid analogues and lipid droplet dyes for live cell imaging and flow cytometry
- Deuterated and carbon-13-labeled lipids for quantitative LC MS MS lipidomics and flux tracking
- Photoaffinity and click chemistry probes for target identification and lipid protein interaction mapping
- Enzymatic and colorimetric detection reagents for high-throughput screening of metabolic fluxes
Applications
- Antiobesity Target Validation: Identifying and validating enzymatic and receptor targets controlling lipolysis, lipogenesis, and energy expenditure in white and brown adipose tissues.
- Lipotoxicity and Insulin Resistance Research: Investigating ectopic lipid deposition in muscle, liver, and beta cells to clarify mechanisms driving nutrient-induced insulin resistance and cell death.
- Fatty Liver Disease and NASH Studies: Quantifying hepatic triglyceride accumulation, diacylglycerol signaling, and lipid peroxidation to support therapeutic evaluation for steatohepatitis.
- Adipose Tissue Remodeling and Thermogenesis: Evaluating white adipose tissue browning, mitochondrial UCP1 activation, and thermogenic lipid mediator activity in response to lead compounds.
- Targeted Gene Therapy Delivery: Optimizing tissue-targeted LNPs to deliver gene silencing or expression therapies directly to metabolic tissues.
Advantages
Analytical Grade Quality & Rigorous Certification
Rigorous quality assurance and quality control protocols utilizing advanced analytical platforms, including high-performance liquid chromatography (HPLC), mass spectrometry (MS), nuclear magnetic resonance (NMR), and thin-layer chromatography (TLC), guarantee exceptionally precise lipid profiling, verified chemical identity, and superior batch-to-batch reproducibility across all biological assays.
Broad Pathway Coverage & Custom Synthesis
An expansive catalog featuring over 4,000 distinct, highly characterized lipid entities, complemented by flexible custom synthesis services, delivers comprehensive coverage across critical metabolic pathways governing systemic energy balance, adipocyte differentiation, adaptive thermogenesis, and cellular lipotoxicity.
Custom Formulation, Blending & Packaging
Tailored formulation and packaging solutions designed to align perfectly with your experimental workflows, offering flexible package sizes, specialized aliquot choices, and proprietary custom lipid blending services engineered specifically for high-throughput assays and precision LNP drug delivery formulations.
Publication Data
Title: Lipid remodeling of adipose tissue in metabolic health and disease
Journal: Experimental & Molecular Medicine, 2023
DOI: https://doi.org/10.1038/s12276-023-01071-4
Summary: Leveraging high-throughput lipidomics, this review systematically summarizes the enzymatic and molecular mechanisms underlying dynamic lipid remodeling in adipose tissue across physiological, pharmacological, and pathological conditions, with a focus on newly identified adipose-derived bioactive lipid mediators (such as FAHFAs, lysophospholipids, and specific sphingolipids). It reveals that pathological states like obesity, insulin resistance, and cardiovascular diseases trigger membrane lipid shifts and the accumulation of lipotoxic species (e.g., ceramides and diacylglycerols), while elucidating the paracrine and endocrine roles of bioactive lipid mediators in regulating adipocyte differentiation, inflammation, and metabolic flexibility.
By shifting the paradigm of adipose tissue from a passive energy reservoir to an active endocrine organ, this work highlights targeting the metabolic pathways of bioactive lipid mediators as a promising therapeutic strategy for obesity-related metabolic diseases.
Fig. 1 Adipocyte metabolic consequences induced by the loss of key lipid biosynthetic and metabolic enzymes. (Cho, et al., 2023)
Customer Review
Transformative Lipid Quality for Target Engagement
"Integrating Protheragen's lipid standards into our anti-obesity pipeline provided exceptional accuracy in quantifying lipidome remodeling within visceral adipose tissue. The batch-to-batch consistency and high purity of their custom stable isotope-labeled lipids were instrumental in generating highly reproducible data and validating our lead target engagement assays." Dr. E** R***, Research Scientist
Unrivaled Ionizable Lipids for Tissue-Targeted LNP Delivery
"Delivering RNA payloads directly to adipose tissues is a major challenge. Protheragen's custom ionizable lipid libraries demonstrated outstanding delivery efficiency and specificity in our LNP formulations. Every batch arrives with flawless purity, complete analytical documentation, and reliable biological activity."Dr. M** T**, Medicinal Chemist
Frequently Asked Questions
-
Can Protheragen synthesize custom stable isotope labeled lipids?
Yes. Our synthetic team routinely produces deuterium- and carbon-13-labeled lipid species as internal standards for quantitative LC MS MS lipidomics and metabolic flux studies. Contact us to discuss your requirements.
-
What are the recommended storage conditions to prevent lipid oxidation?
Sensitive lipids and polyunsaturated fatty acids are packaged under argon gas in amber vials. Store at minus 20 degrees Celsius or minus 80 degrees Celsius away from light, reconstituting in anhydrous solvents immediately before use.
-
Do you offer custom lipid synthesis services?
Yes, we offer comprehensive custom lipid synthesis and tailored chemical modification services. Turnaround times typically range from four to eight weeks, complete with regular milestone updates. Contact us with your target structure today to receive a personalized quote and timeline assessment.
Combining lipid biochemistry expertise with advanced analytical and formulation technologies, Protheragen helps biopharmaceutical partners accelerate target discovery and optimize lipid delivery vehicles. Whether you are probing the fundamentals of intracellular lipid storage or formulating next-generation target-directed LNPs, our comprehensive suite of lipid products provides the quality, consistency, and precision your research demands. Explore our detailed product catalogs, download technical datasheets, or contact us to discuss custom synthesis and formulation services.
Reference
- Cho, Y.K.; et al. Lipid remodeling of adipose tissue in metabolic health and disease. Experimental & Molecular Medicine. 2023, 55(9): 1955-1973. (CC BY 4.0)